Fusion Antibodies reports second-half rebound as new commercial strategy pays off
–News Direct– Fusion Antibodies PLC (AIM:FAB) CEO Adrian Kinkaid joined Proactive's Stephen Gunnion with more on the company that specialises in various stages of antibody development, excluding GMP production for…